Cite
HARVARD Citation
Dizman, N. et al. (n.d.). 645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis. Journal for immunotherapy of cancer. p. A387. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dizman, N. et al. (n.d.). 645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis. Journal for immunotherapy of cancer. p. A387. [Online].